Zobrazeno 1 - 3
of 3
pro vyhledávání: '"ACEI, ACE inhibitors"'
Autor:
Giulio Russo, Daniela Pedicino, Felicita Andreotti, Filippo Crea, Ramona Vinci, Alessia D’Aiello, Giovanna Liuzzo, R De Cristofaro
Publikováno v:
International Journal of Cardiology
We concisely review clinical, autopsy, experimental and molecular data of 2019 coronavirus disease (COVID-19). Angiotensin-converting enzyme 2 disruption and thromboinflammatory microangiopathy emerge as distinctive features. Briefly, entry of the vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d904f20caa50580cddb8231f231dea01
http://hdl.handle.net/10807/174388
http://hdl.handle.net/10807/174388
Publikováno v:
Biochemical Pharmacology
Graphical abstract
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3288262888c0c58d8afaae1b90afb12
http://europepmc.org/articles/PMC7250789
http://europepmc.org/articles/PMC7250789
Publikováno v:
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy, Vol 143, Iss, Pp 112095-(2021)
Biomedicine & Pharmacotherapy, Vol 143, Iss, Pp 112095-(2021)
Angiotensin-converting enzyme-2 (ACE2) is one of the major components of the renin-angiotensin system (RAS) and participates in the physiological functions of the cardiovascular system and lungs. Recent studies identified ACE2 as the receptor for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f91690e839bb7519c3dfe5b2c38f703
http://europepmc.org/articles/PMC8403698
http://europepmc.org/articles/PMC8403698